Skip to main content
Erschienen in: Journal of Cancer Survivorship 5/2021

20.10.2020

Long-term follow-up 3 years after a randomized rehabilitation study among radiated prostate cancer survivors

verfasst von: Karin B. Dieperink, Steinbjørn Hansen, Lis Wagner, Lisbeth R. Minet, Olfred Hansen

Erschienen in: Journal of Cancer Survivorship | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In the Rehabilitation of Prostate Cancer (RePCa) study, the intervention reduced early adverse effects in prostate cancer 6 months after radiotherapy. This 3-year follow-up study assesses late adverse effects, evaluates rehabilitative long-term effects and identifies patients who benefit the most.

Design

RePCa was a randomized clinical trial with multidisciplinary rehabilitation (n = 79) or usual care (n = 82). The intervention during the first 6 months consisted of consultations by nurses and physiotherapists focusing on psychosocial support and physical activity, respectively. Here we report the 3-year follow-up. Data consisted of disease-specific quality of life (EPIC-26), general quality of life (SF-12) and pelvic floor strength measured by electromyography.

Results

One hundred forty-three patients (92%) responded. The primary outcome urinary irritative sum-score was no longer significantly different between groups. In patients with moderate-severe urinary problems at baseline, we observed a significant long-term effect on the urinary irritative sum-score in favour of the intervention (+ 13.4 points P = .014). More patients had moderate-severe bowel problems in the control group (n = 10; 14%) compared to the intervention group (n = 2; 3%) (P = .016). Pelvic floor strength deteriorated significantly in both groups.

Conclusion

The short-term rehabilitation was beneficial but of limited benefit in the long term for all patients. A significant and clinically relevant effect was found in irradiated prostate cancer patients with moderate-severe urinary problems at baseline. In both groups, pelvic floor strength was weakened during follow-up.

Impact for cancer survivors

Prior research showed patients benefit from early rehabilitation. Identification of patients with moderate-severe urinary problems followed by a focused rehabilitation during the first 6 months after radiotherapy results in long-term improvement. Radiated patients have to be aware of their pelvic floor strength.

Implications for Cancer Survivors

Patients can be informed that they benefit from early rehabilitation, and they cannot expect larger changes in adverse effects within the first years, but they have to be aware of their pelvic floor strength. Future rehabilitation studies could be applied mainly to patients with assessed rehabilitation needs after radiotherapy and intensified with long-term follow-up.
Literatur
1.
Zurück zum Zitat Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.CrossRefPubMed Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.CrossRefPubMed
2.
Zurück zum Zitat Holch P, Henry AM, Davidson S, Gilbert A, Routledge J, Shearsmith L, et al. Acute and late adverse events associated with radical radiation therapy prostate cancer treatment: a systematic review of clinician and patient toxicity reporting in randomized controlled trials. Int J Radiat Oncol Biol Phys. 2017;97(3):495–510.CrossRefPubMed Holch P, Henry AM, Davidson S, Gilbert A, Routledge J, Shearsmith L, et al. Acute and late adverse events associated with radical radiation therapy prostate cancer treatment: a systematic review of clinician and patient toxicity reporting in randomized controlled trials. Int J Radiat Oncol Biol Phys. 2017;97(3):495–510.CrossRefPubMed
3.
Zurück zum Zitat Budaus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61(1):112–27.CrossRefPubMed Budaus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61(1):112–27.CrossRefPubMed
5.
Zurück zum Zitat Harmenberg U, Hamdy FC, Widmark A, Lennernas B, Nilsson S. Curative radiation therapy in prostate cancer. Acta Oncol. 2011;50(Suppl 1):98–103.CrossRefPubMed Harmenberg U, Hamdy FC, Widmark A, Lennernas B, Nilsson S. Curative radiation therapy in prostate cancer. Acta Oncol. 2011;50(Suppl 1):98–103.CrossRefPubMed
6.
Zurück zum Zitat Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009;373:301–8.CrossRefPubMed Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009;373:301–8.CrossRefPubMed
7.
Zurück zum Zitat Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B, Mason MD. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treat Rev. 2009;35(1):9–17.CrossRefPubMed Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B, Mason MD. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treat Rev. 2009;35(1):9–17.CrossRefPubMed
8.
Zurück zum Zitat Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol (Stockh). 2012;51(6):722–9.CrossRef Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol (Stockh). 2012;51(6):722–9.CrossRef
9.
Zurück zum Zitat Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C. Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review. J Cancer Surviv Res Pract. 2016;10(2):351–62.CrossRef Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C. Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review. J Cancer Surviv Res Pract. 2016;10(2):351–62.CrossRef
10.
Zurück zum Zitat Higano CS. Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(30):3720–5.CrossRef Higano CS. Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(30):3720–5.CrossRef
11.
Zurück zum Zitat Dieperink KB, Mark K, Mikkelsen TB. Marital rehabilitation after prostate cancer – a matter of intimacy. Int J Urol Nurs. 2016;10(1):21–9.CrossRef Dieperink KB, Mark K, Mikkelsen TB. Marital rehabilitation after prostate cancer – a matter of intimacy. Int J Urol Nurs. 2016;10(1):21–9.CrossRef
12.
Zurück zum Zitat Harrington JM, Jones EG, Badger T. Body image perceptions in men with prostate cancer. OncolNursForum. 2009;36(2):167–72. Harrington JM, Jones EG, Badger T. Body image perceptions in men with prostate cancer. OncolNursForum. 2009;36(2):167–72.
13.
Zurück zum Zitat Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv. 2010;4:128–39.CrossRefPubMed Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv. 2010;4:128–39.CrossRefPubMed
14.
Zurück zum Zitat Frisk J. Managing hot flushes in men after prostate cancer--a systematic review. Maturitas. 2010;65(1):15–22.CrossRefPubMed Frisk J. Managing hot flushes in men after prostate cancer--a systematic review. Maturitas. 2010;65(1):15–22.CrossRefPubMed
15.
Zurück zum Zitat Williams MB, Hernandez J, Thompson I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol. 2005;173(4):1067–71.CrossRefPubMed Williams MB, Hernandez J, Thompson I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol. 2005;173(4):1067–71.CrossRefPubMed
16.
Zurück zum Zitat Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(34):5038–45.CrossRef Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(34):5038–45.CrossRef
17.
Zurück zum Zitat Collier A, Ghosh S, McGlynn B, Hollins G. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review. Am J Clin Oncol. 2012;35(5):504–9.CrossRefPubMed Collier A, Ghosh S, McGlynn B, Hollins G. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review. Am J Clin Oncol. 2012;35(5):504–9.CrossRefPubMed
18.
Zurück zum Zitat Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2013;189(1 Suppl):S34–44.PubMed Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2013;189(1 Suppl):S34–44.PubMed
19.
Zurück zum Zitat Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;69(4):693–703.CrossRefPubMed Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;69(4):693–703.CrossRefPubMed
20.
Zurück zum Zitat Teleni L, Chan RJ, Chan A, Isenring EA, Vela I, Inder WJ, et al. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials. Endocr Relat Cancer. 2016;23(2):101–12.CrossRefPubMed Teleni L, Chan RJ, Chan A, Isenring EA, Vela I, Inder WJ, et al. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials. Endocr Relat Cancer. 2016;23(2):101–12.CrossRefPubMed
21.
Zurück zum Zitat Dieperink KB, Johansen C, Hansen S, Wagner L, Andersen KK, Minet LR, et al. The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients. Br J Cancer. 2013;109:3005–13.CrossRefPubMedCentralPubMed Dieperink KB, Johansen C, Hansen S, Wagner L, Andersen KK, Minet LR, et al. The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients. Br J Cancer. 2013;109:3005–13.CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Benner P, Wrubel J. In: Evans N, editor. The primacy of caring. Stress and coping in health and illness. Addison-Wesley Publishing Company; 1989. p. 1–425. First edition Benner P, Wrubel J. In: Evans N, editor. The primacy of caring. Stress and coping in health and illness. Addison-Wesley Publishing Company; 1989. p. 1–425. First edition
23.
Zurück zum Zitat Miller WR, Rollnick S. Motivational interviewing, preparing people to change addictive behavior. New York: The Guildford Press; 2002. Miller WR, Rollnick S. Motivational interviewing, preparing people to change addictive behavior. New York: The Guildford Press; 2002.
24.
Zurück zum Zitat Dorey G, Glazener C, Buckley B, Cochran C, Moore K. Developing a pelvic floor muscle training regimen for use in a trial intervention. Physiotherapy. 2009;95(3):199–209.CrossRefPubMed Dorey G, Glazener C, Buckley B, Cochran C, Moore K. Developing a pelvic floor muscle training regimen for use in a trial intervention. Physiotherapy. 2009;95(3):199–209.CrossRefPubMed
25.
Zurück zum Zitat Dorey G. Pelvic dysfunction in men. Diagnosis and treatment of male incontinence and erectile dysfunction. Wiley; 2006. p. 1–221. First edition Dorey G. Pelvic dysfunction in men. Diagnosis and treatment of male incontinence and erectile dysfunction. Wiley; 2006. p. 1–221. First edition
26.
Zurück zum Zitat Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed
27.
Zurück zum Zitat Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76(5):1245–50.CrossRefPubMed Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76(5):1245–50.CrossRefPubMed
28.
Zurück zum Zitat Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.CrossRefPubMed Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.CrossRefPubMed
29.
Zurück zum Zitat Dorey G. A clinical overview of the treatment of post-prostatectomy incontinence. Br J Nurs. 2007;16(19):1194–9.CrossRefPubMed Dorey G. A clinical overview of the treatment of post-prostatectomy incontinence. Br J Nurs. 2007;16(19):1194–9.CrossRefPubMed
30.
Zurück zum Zitat D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.CrossRefPubMed D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.CrossRefPubMed
31.
Zurück zum Zitat Handberg C, Lomborg K, Nielsen CV, Oliffe JL, Midtgaard J. Understanding male cancer patients’ barriers to participating in cancer rehabilitation. Eur J Cancer Care (Engl). 2015;24(6):801–11.CrossRef Handberg C, Lomborg K, Nielsen CV, Oliffe JL, Midtgaard J. Understanding male cancer patients’ barriers to participating in cancer rehabilitation. Eur J Cancer Care (Engl). 2015;24(6):801–11.CrossRef
32.
Zurück zum Zitat Handberg C, Nielsen CV, Lomborg K. Men’s reflections on participating in cancer rehabilitation: a systematic review of qualitative studies 2000-2013. Eur J Cancer Care (Engl). 2014;23(2):159–72.CrossRef Handberg C, Nielsen CV, Lomborg K. Men’s reflections on participating in cancer rehabilitation: a systematic review of qualitative studies 2000-2013. Eur J Cancer Care (Engl). 2014;23(2):159–72.CrossRef
34.
Zurück zum Zitat Handberg C, Thorne S, Maribo T. When a policy decision meets practice realities: the case of cancer survivorship care and rehabilitation needs assessment. Eur J Oncol Nurs. 2018;33:70–7.CrossRefPubMed Handberg C, Thorne S, Maribo T. When a policy decision meets practice realities: the case of cancer survivorship care and rehabilitation needs assessment. Eur J Oncol Nurs. 2018;33:70–7.CrossRefPubMed
35.
Zurück zum Zitat Milios JE, Ackland TR, Green DJ. Pelvic floor muscle training in radical prostatectomy: a randomized controlled trial of the impacts on pelvic floor muscle function and urinary incontinence. BMC Urol. 2019;19(1):116.CrossRefPubMedCentralPubMed Milios JE, Ackland TR, Green DJ. Pelvic floor muscle training in radical prostatectomy: a randomized controlled trial of the impacts on pelvic floor muscle function and urinary incontinence. BMC Urol. 2019;19(1):116.CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Dieperink KB, Wagner L, Hansen S, Hansen O. Embracing life after prostate cancer. A male perspective on treatment and rehabilitation. Eur J Cancer Care. 2013;22(4):549–58.CrossRef Dieperink KB, Wagner L, Hansen S, Hansen O. Embracing life after prostate cancer. A male perspective on treatment and rehabilitation. Eur J Cancer Care. 2013;22(4):549–58.CrossRef
37.
Zurück zum Zitat Winters-Stone KM, Lyons KS, Dobek J, Dieckmann NF, Bennett JA, Nail L, et al. Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the exercising together project. J Cancer Surviv Res Pract. 2016;10(4):633–44.CrossRef Winters-Stone KM, Lyons KS, Dobek J, Dieckmann NF, Bennett JA, Nail L, et al. Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the exercising together project. J Cancer Surviv Res Pract. 2016;10(4):633–44.CrossRef
38.
Zurück zum Zitat Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM. Cardiovascular and metabolic effects of androgen-deprivation therapy for prostate cancer. J Oncol Pract. 2018;14(10):580–7.CrossRefPubMed Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM. Cardiovascular and metabolic effects of androgen-deprivation therapy for prostate cancer. J Oncol Pract. 2018;14(10):580–7.CrossRefPubMed
39.
Zurück zum Zitat Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63(5):800–9.CrossRefPubMed Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63(5):800–9.CrossRefPubMed
40.
Zurück zum Zitat Lemanska A, Dearnaley DP, Jena R, Sydes MR, Faithfull S. Older age, early symptoms and physical function are associated with the severity of late symptom clusters for men undergoing radiotherapy for prostate cancer. Clin Oncol (R Coll Radiol). 2018;30(6):334–45.CrossRef Lemanska A, Dearnaley DP, Jena R, Sydes MR, Faithfull S. Older age, early symptoms and physical function are associated with the severity of late symptom clusters for men undergoing radiotherapy for prostate cancer. Clin Oncol (R Coll Radiol). 2018;30(6):334–45.CrossRef
41.
Zurück zum Zitat Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1:Cd012529.PubMed Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, et al. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. 2018;1:Cd012529.PubMed
42.
Zurück zum Zitat Treanor C, Kyaw T, Donnelly M. An international review and meta-analysis of prehabilitation compared to usual care for cancer patients. J Cancer Surviv Res Pract. 2018;12(1):64–73.CrossRef Treanor C, Kyaw T, Donnelly M. An international review and meta-analysis of prehabilitation compared to usual care for cancer patients. J Cancer Surviv Res Pract. 2018;12(1):64–73.CrossRef
43.
Zurück zum Zitat Hodges PW, Stafford RE, Hall L, Neumann P, Morrison S, Frawley H, et al. Reconsideration of pelvic floor muscle training to prevent and treat incontinence after radical prostatectomy. Urol Oncol. 2020;38(5):354–71.CrossRefPubMed Hodges PW, Stafford RE, Hall L, Neumann P, Morrison S, Frawley H, et al. Reconsideration of pelvic floor muscle training to prevent and treat incontinence after radical prostatectomy. Urol Oncol. 2020;38(5):354–71.CrossRefPubMed
Metadaten
Titel
Long-term follow-up 3 years after a randomized rehabilitation study among radiated prostate cancer survivors
verfasst von
Karin B. Dieperink
Steinbjørn Hansen
Lis Wagner
Lisbeth R. Minet
Olfred Hansen
Publikationsdatum
20.10.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 5/2021
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00958-9

Weitere Artikel der Ausgabe 5/2021

Journal of Cancer Survivorship 5/2021 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.